Eculizumab in Posttransplant TMA: Unproven Benefit

Eculizumab in Posttransplant TMA: Unproven Benefit

Saved in:

Bibliographic Details
Main Authors:	Romy N. Bouwmeester, Jack F.M. Wetzels, Nicole C.A.J. van de Kar
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924016358
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Response to Letter to the Editor From Bouwmeester RN et al.: “Eculizumab in Postransplant TMA: Unproven Benefit.”
by: Federica Maritati, et al.
Published: (2024-06-01)

A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic microangiopathy
by: Caroline Duineveld, et al.
Published: (2024-05-01)

“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
by: Federica Maritati, et al.
Published: (2024-04-01)

Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study
by: Caroline Duineveld, et al.
Published: (2024-01-01)

Letter to the editor about: “Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
by: Simon Ville, et al.
Published: (2024-06-01)

Hydroxychloroquine in COVID-19 widespread use despite unproven benefit
by: Pranav Ish
Published: (2022-01-01)

Cholecystectomy-induced thrombotic microangiopathy (TMA) in a postpartum patient successfully treated with eculizumab: a case report
by: Ashley Meyer, et al.
Published: (2024-12-01)

Response to Letter to the Editor From Ville S. et al. About: “Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
by: Federica Maritati, et al.
Published: (2024-06-01)

Research on empowering digital government construction through the implementation of “unproven province” in Shandong province
by: HOU Xinyue
Published: (2025-05-01)

Living with Atypical Hemolytic Uremic Syndrome in the Netherlands: Patient and Family Perspective
by: Romy N. Bouwmeester, et al.
Published: (2024-07-01)

L’argomento del terzo uomo (TMA) e Platone.
by: Vittorio Ricci
Published: (2025-05-01)

The Impact of Posttransplant Lymphoproliferative Disease in High-risk Kidney Transplant Recipients: Benefits of Prevention
by: Bryce A. Kiberd, MD, et al.
Published: (2025-05-01)

Posttransplant Lymphoproliferative Disorders
by: Hazem A. H. Ibrahim, et al.
Published: (2012-01-01)

Posttransplant Intrarenal Lymphangiectasia
by: Ali Kord, et al.
Published: (2020-01-01)

Translating biomarker insights into practice: a path forward in TA-TMA management
by: Sonata Jodele, et al.
Published: (2025-05-01)

The prognostic value of posttransplant chimerism
by: A. A. Sipol, et al.
Published: (2022-11-01)

An Unusual Immediate Posttransplant Eruption
by: Ravi K. Mallavarapu, et al.
Published: (2025-02-01)

WCN25-675 SPECTRUM AND CLINICAL PROFILE OF TMA AT A TERTIARY CARE CENTRE
by: KAVITHA MUDALIAR, et al.
Published: (2025-02-01)

The TMA team and TTP pathway improved outcomes in a cohort with Thrombotic thrombocytopenic purpura
by: Samuel A. Merrill, et al.
Published: (2025-01-01)

Ophthalmoplegia and Tumor Lysis Syndrome: An Uncommon Presentation of Posttransplant Lymphoproliferative Disorder
by: Lauren M. Granat, et al.
Published: (2022-09-01)

Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous Nephropathy
by: Coralien H. Vink, et al.
Published: (2024-12-01)

Method development and validation for determination of antihemolytic activity of eculizumab (Soliris)
by: E. Yu. Prudnikova, et al.
Published: (2017-03-01)

Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature
by: Zaid Ammari, et al.
Published: (2018-01-01)

Transplant-associated Thrombotic Microangiopathy: An Enigma Treated with Eculizumab
by: S. Ravitej, et al.
Published: (2024-10-01)

Prediksi Tinggi Muka Air (TMA) Untuk Deteksi Dini Bencana Banjir Menggunakan SVR-TVIWPSO
by: Arief Andy Soebroto, et al.
Published: (2015-07-01)

Evaluation of phytotoxicity and genotoxicity of TMA-stabilized iron-oxide nanoparticle in corn (Zea mays) young plants
by: Mihaela Răcuciu, et al.
Published: (2025-05-01)

Changing trends in the management of posttransplant ureteric stricture
by: Sunirmal Choudhury, et al.
Published: (2024-01-01)

Autoimmune Phenomenon Associated With Posttransplant Lymphoproliferative Disorder
by: Pierre Isnard, et al.
Published: (2024-03-01)

Posttransplant Lymphoproliferative Disease after Lung Transplantation
by: Isabel P. Neuringer
Published: (2013-01-01)

The pharmaceutical suitcase trade and the need for multisectoral regulation-unproven COVID-19 (Ivermectin and HCQ remedies unmask an insidious health danger in a Caribbean Island)
by: Sandeep Bhupendra Maharaj, et al.
Published: (2024-12-01)

Comparison of static friction and surface topography of low friction and conventional TMA orthodontic arch wires: An in-vitro study
by: Nouf Alsabti, et al.
Published: (2021-07-01)

ViTMa: A Novel Hybrid Vision Transformer and Mamba for Kinship Recognition in Indonesian Facial Micro-Expressions
by: Ike Fibriani, et al.
Published: (2024-01-01)

CAM/TMA-DPH as a promising alternative to SYTO9/PI for cell viability assessment in bacterial biofilms
by: Tinatini Tchatchiashvili, et al.
Published: (2025-01-01)

Meningococcemia in a vaccinated child receiving eculizumab and review of the literature
by: Diana Üçkardeş, et al.
Published: (2023-02-01)

A Case of Neisseria sicca Bacteremia Due to Eculizumab Therapy
by: Kelly A. Russo, et al.
Published: (2023-06-01)

Podocyte Glucocorticoid Receptor Expression and Treatment Outcome in Idiopathic Nephrotic Syndrome
by: Bartholomeus T. van den Berge, et al.
Published: (2025-07-01)

INFLUENCE OF BONE MARROW MSCs ON THE DEVELOPMENT OF POSTTRANSPLANT CHANGES IN KIDNES
by: N. A. Onishchenko, et al.
Published: (2016-04-01)

Silence before the Storm – Mycotic Aneurysm in Posttransplant Recipient
by: G. Praveen, et al.
Published: (2025-01-01)

Isolated Upper Extremity Posttransplant Lymphoproliferative Disorder in a Child
by: Sarah E. Halula, et al.
Published: (2015-01-01)

Efficacy of iptacopan monotherapy for suboptimal response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria
by: Olesya U. Klimova, et al.
Published: (2025-01-01)